Jacobs & Co
- SEC CIK
- 0001055544
- Latest filing
- Jul 8, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Jacobs & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 90,643
- Value
- $8.20M
- % of portfolio
- 0.7%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 90,643 | $8.20M | 0.7% | −4,932−5.2% | Reduced | Holders |
| Q1 2026 | 95,575 | $7.65M | 0.8% | −4,940−4.9% | Reduced | Holders |
| Q4 2025 | 100,515 | $8.57M | 0.8% | −12,150−10.8% | Reduced | Holders |
| Q3 2025 | 112,665 | $8.76M | 0.8% | −5,647−4.8% | Reduced | Holders |
| Q2 2025 | 118,312 | $9.25M | 0.9% | −7,261−5.8% | Reduced | Holders |
| Q1 2025 | 125,573 | $9.10M | 1.0% | −155−0.1% | Reduced | Holders |
| Q4 2024 | 125,728 | $9.31M | 0.9% | +2,828+2.3% | Added | Holders |
| Q3 2024 | 122,900 | $8.11M | 0.8% | +9,879+8.7% | Added | Holders |
| Q2 2024 | 113,021 | $10.4M | 1.1% | +240+0.2% | Added | Holders |
| Q1 2024 | 112,781 | $10.8M | 1.1% | +2,116+1.9% | Added | Holders |
| Q4 2023 | 110,665 | $8.44M | 1.0% | +3,447+3.2% | Added | Holders |
| Q3 2023 | 107,218 | $7.43M | 0.9% | +3,443+3.3% | Added | Holders |
| Q2 2023 | 103,775 | $9.79M | 1.2% | +1,096+1.1% | Added | Holders |
| Q1 2023 | 102,679 | $8.49M | 1.0% | +933+0.9% | Added | Holders |
| Q4 2022 | 101,746 | $7.59M | 1.0% | +4,397+4.5% | Added | Holders |
| Q3 2022 | 97,349 | $8.04M | 1.2% | +812+0.8% | Added | Holders |
| Q2 2022 | 96,537 | $9.18M | 1.2% | −5,930−5.8% | Reduced | Holders |
| Q1 2022 | 102,467 | $12.1M | 1.3% | −2,975−2.8% | Reduced | Holders |
| Q4 2021 | 105,442 | $13.7M | 1.4% | −1,310−1.2% | Reduced | Holders |
| Q3 2021 | 106,752 | $12.1M | 1.4% | −2,376−2.2% | Reduced | Holders |
| Q2 2021 | 109,128 | $11.3M | 1.3% | −4,410−3.9% | Reduced | Holders |
| Q1 2021 | 113,538 | $9.50M | 1.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.